Lumida
/ACLS
⌘K
Axcelis Technologies Inc

Axcelis Technologies Inc

ACLS
$136.42USD-2.10%-2.92 today

MARKET CAP

4.2B

P/E (TTM)

30.6x

FWD P/E

31.4x

DAY RANGE

$128 – $141

52W RANGE

$66
$194

AI Summary

Stalk
TrimMedium

ACLS remains in a Stage 4 decline with active Bearish Pivot Point confirming medium-term bearish control. Price trades below declining 9 and 21 EMAs and recently bounced into them without clear rejection, so we defer selling until price tests and is rejected by the EMA zone. The long-term uptrend above the 200 DMA is intact but not actionable in the current downtrend.

  • EV/AI adoption drives silicon carbide and gallium nitride revenue growth.
  • Veeco merger expected to unlock complementary technology and cost synergies.
  • Stock trades ~63% above its $87.54 intrinsic value estimate.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Axcelis Technologies (NASDAQ: ACLS) is a leading semiconductor equipment manufacturer specializing in ion implantation solutions crucial for advanced semiconductor devices. The company has a dominant position in the growing semiconductor market, particularly benefiting from the demand for silicon carbide and gallium nitride technologies, which are increasingly relevant in electric vehicles and AI applications. With its upcoming merger with Veeco Instruments, Axcelis is strategically positioned to leverage synergies and enhance its competitive edge in the ever-evolving semiconductor landscape.

Bull says

  • EV/AI adoption drives silicon carbide and gallium nitride revenue growth.
  • Veeco merger expected to unlock complementary technology and cost synergies.
  • Book-to-bill ratio at 1.0 indicates rising order intake.
  • Strong liquidity and momentum factors and positive analyst revisions.
  • Share buybacks of $45M in Q2 reinforce shareholder commitment.
  • Analyst consensus price targets imply ~18% upside potential.

Bear says

  • Stock trades ~63% above its $87.54 intrinsic value estimate.
  • Shares down 13.2% in past month amid valuation skepticism.
  • High market volatility and negative growth momentum pose significant risks.
  • Execution and integration risks around Veeco merger could disrupt operations.
  • Cyclical exposure: DRAM/HBM demand uncertainty while NAND remains weak.
  • Weak earnings yield and elevated commodity sensitivity pressure valuation.

Investment themes with ACLS

Semiconductors -0.94%

Chips powering modern tech and AI growth

AMD · AMAT · LRCX
Most Shorted Stocks +0.54%

Stocks with highest short interest

LITE · FSLY · SPHR
Short Ideas -0.14%

Stocks recommended for short-selling opportunities

XBI · FXI · ARKG

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-08-2026neutral

Transcript signals

Bull points

  • we feel a little bit better today than we did three months ago in general.
  • So we think the combination of these things is pretty encouraging and, again, sets the stage for maybe some momentum into 2027.
  • We expect pretty strong growth in memory. And that's all DRAM. Our expectation embedded in our 2026 expectation is not much NAND.

Bear points

  • We still expect 2026 general mature to be down year over year.
  • For this year, based on our backlog, based on the scheduled shipments that we have, we still feel that those markets are going to be down this year.
  • for example, in Q2, memory is going to be a little softer sequentially.
Read full transcript analysis ›